Guilhot, J., Saußele, S., & Hehlmann, R. (2012). Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: A proposal by the European LeukemiaNet. Blood, 119(25), . https://doi.org/10.1182/blood-2011-10-383711
Chicago-Zitierstil (17. Ausg.)Guilhot, Joëlle, Susanne Saußele, und Rüdiger Hehlmann. "Definitions, Methodological and Statistical Issues for Phase 3 Clinical Trials in Chronic Myeloid Leukemia: A Proposal by the European LeukemiaNet." Blood 119, no. 25 (2012). https://doi.org/10.1182/blood-2011-10-383711.
MLA-Zitierstil (9. Ausg.)Guilhot, Joëlle, et al. "Definitions, Methodological and Statistical Issues for Phase 3 Clinical Trials in Chronic Myeloid Leukemia: A Proposal by the European LeukemiaNet." Blood, vol. 119, no. 25, 2012, https://doi.org/10.1182/blood-2011-10-383711.